{"author_name":"uneyama","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","version":"1.0","categories":["NTP"],"height":"190","provider_name":"Hatena Blog","type":"rich","title":"\u7c73\u56fd\u306b\u304a\u3051\u308b\u5316\u5b66\u7269\u8cea\u3068\u533b\u85ac\u54c1\u306e\u5b89\u5168\u6027\u8a55\u4fa1\u306e\u65b0\u3057\u3044\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u78ba\u7acb\u3059\u308b\u305f\u3081\u306e\u6226\u7565\u7684\u30ed\u30fc\u30c9\u30de\u30c3\u30d7","description":"A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States January 2018 https://ntp.niehs.nih.gov/pubhealth/evalatm/natl-strategy/index.html\u5b98\u5831\u3067\u516c\u5f0f\u306b\u544a\u77e5 Fed. Reg. 83(35): page 7487, Feb. 21, 2018 https://www.federalregister.gov/docum\u2026","provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20180222%2Fp4\" title=\"\u7c73\u56fd\u306b\u304a\u3051\u308b\u5316\u5b66\u7269\u8cea\u3068\u533b\u85ac\u54c1\u306e\u5b89\u5168\u6027\u8a55\u4fa1\u306e\u65b0\u3057\u3044\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u78ba\u7acb\u3059\u308b\u305f\u3081\u306e\u6226\u7565\u7684\u30ed\u30fc\u30c9\u30de\u30c3\u30d7 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","image_url":null,"width":"100%","url":"https://uneyama.hatenadiary.jp/entry/20180222/p4","blog_url":"https://uneyama.hatenadiary.jp/","author_url":"https://blog.hatena.ne.jp/uneyama/","published":"2018-02-22 00:00:03"}